Best Formulations, a Sirio Company, Earns Sixth Consecutive ‘A’ Rating in National Sanitation Foundation Recertification Audit.
Achievement affirms company’s commitment to quality, compliance and operational excellence in the nutraceutical industry.
City of Industry, CA – Best Formulations, a Sirio Pharma Company (Sirio), a leading global nutraceutical contract development and manufacturing organization (CDMO), has successfully completed its National Sanitation Foundation (NSF) recertification audit, securing an ‘A’ rating for the sixth consecutive year. This achievement underscores Sirio’s unwavering organization-wide commitment to quality, compliance and operational excellence, ensuring customers receive the highest standard of nutraceutical products.
The NSF 455-2 audit is a rigorous current Good Manufacturing Practice (cGMP) assessment incorporating the 21 CFR Part 111 Dietary Supplement Compliance Guide requirements, along with recognized industry best practices. Administered by NSF, a globally recognized organization dedicated to public health and safety, the audit validates a company’s quality systems, product safety and operational integrity. As a critical benchmark in the dietary supplement industry, NSF certification assures customers that a company adheres to stringent safety and quality protocols, reinforcing trust in the manufacturer’s goods and services.
During the audit, the NSF commended Best Formulations for its robust quality management system, meticulous documentation, and attention to detail during facility walkthroughs.
“Earning an ‘A’ rating for six consecutive years showcases the dedication and expertise of our entire team,” said Kayla Pham, Vice President of Quality at Best Formulations. “This certification is not merely about compliance; it reinforces the trust customers place in our consistent ability to deliver high-quality nutraceuticals.”
About SIRIO Pharma
Established in 1993, SIRIO Pharma Co., Ltd (SIRIO) is a leading global nutraceutical contract development and manufacturing organization (CDMO) with extensive expertise in an array of delivery formats, including gummies, softgels, capsules, tablets, powders, functional beverages, probiotics, and other innovative dosage forms. Dedicated to excellence in product development and manufacturing. SIRIO operates multiple state-of-the-art manufacturing sites across the United States, Germany and China.
In 2023, SIRIO acquired Best Formulations, further solidifying its position as a premier global nutraceutical CDMO, and significantly enhancing its manufacturing capabilities and capacity – with a notable focus on bolstering its presence in North America. For more information, visit
www.siriopharma.com.
